Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-10

Clinical Trial Update: Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating omega-3 fatty acid supplements to prevent cachexia in patients with head and neck cancer undergoing radiochemotherapy has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids supplement (Omega-3 fatty acids)

Snippet

Sponsor: General Hospital Groeninge | Conditions: Cancer Cachexia, Head and Neck Cancer | Phase 2, Phase 3 | Status: COMPLETED